John N Bonfiglio
- Role
- Board Member at Sequella, Inc
- Location
- Denver, CO, US
- LinkedIn followers
- 500 followers
Experience
Board Member
Oct 2020 — Present · Rockville, MD, US
Sequella is developing new anti-infectives to treat resistant Tuberculosis and other pathogenic diseases. The company has completed a a Phase 2b study and will be moving to a Phase 3 study or approval in the next 12-18 months. Sequella has several drugs in its pipeline and has received over $70M in government grants to move their development strategies forward.
Education
UC San Diego
PhD, Organic Chemistry
1976 — 1980
Pepperdine University
MBA, Business
1990 — 1992
Stony Brook University
Bachelor of Science (BS), Chemistry
1972 — 1976
University of California, Berkeley
Post doctoral Fellow, organometallic chemistry
1980 — 1981
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.